accountPfizer Inc. and Endo Pharmaceuticals agreed to resolve Medicaid fraud allegations by paying the State of Texas a total of $36.34 million. Both pharmaceutical companies were accused of filing false price reports with Medicaid. The false price reports allegedly misstated the prices charged for their pharmaceutical products.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to False Price Reports Result in Medicaid Fraud Settlement by Pfizer and Endo Pharmaceuticals
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account